The second highest year on record, 2023 saw huge PE interest in life sciences and biopharma sectors.
Here are three more key notes that ASC leaders need to know:
- The first half of 2022 saw a continuation of 2021’s record-breaking healthcare private equity deal pace, but transactions slowed in the second half of the year.
- Value-based care and primary care continued to draw investment from private equity groups.
- More than 40 exits valued above $500 million were closed in 2022.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
